+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Anti-Thyroid Drugs Global Market Report 2020

  • ID: 4855989
  • Report
  • November 2019
  • Region: Global
  • 200 pages
  • The Business Research Company
1 of 5

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott Laboratories
  • AbbVie Inc
  • Allergan
  • Amgen Inc
  • GlaxoSmithKline plc
  • Lannett Company Inc.
  • MORE
Anti-Thyroid Drugs Market Global Report 2020 from the author provides strategists, marketers and senior management with the critical information they need to assess the global anti-thyroid drugs market.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Description:
Where is the largest and fastest growing market for the anti-thyroid drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Anti-Thyroid Drugs Market Global Report from the author answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market
  • The Market Characteristics section of the report defines and explains the market.
  • The Market Size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market Segmentations break down market into sub markets.
  • The Regional and Country section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive Landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The Trends and Strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
Scope
  • Markets Covered: 1) By Drug Type: Thionamides (Inhibition of hormone synthesis), Iodides (Inhibition of hormone release) 2) By Route of Administration: Oral, Intravenous, Others
  • Companies Mentioned: Mylan N.V., Abbott Laboratories, GlaxoSmithKline plc, Merck & Co., AbbVie, Inc.
  • Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA
  • Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
  • Time Series: Five years historic and forecast.
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • AbbVie Inc
  • Allergan
  • Amgen Inc
  • GlaxoSmithKline plc
  • Lannett Company Inc.
  • MORE
1. Executive Summary

2. Anti-Thyroid Drugs Market Characteristics

3. Anti-Thyroid Drugs Market Size And Growth
3.1. Global Anti-Thyroid Drugs Historic Market, 2015 - 2019, $ Billion
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
3.2. Global Anti-Thyroid Drugs Forecast Market, 2019 - 2022F, 2025F, 2030F, $ Billion
3.2.1. Drivers Of The Market
3.2.2. Restraints On the Market

4. Anti-Thyroid Drugs Market Segmentation
4.1. Global Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Thionamides (Inhibition of hormone synthesis) Iodides (Inhibition of hormone release)
4.2. Global Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Oral Intravenous
  • Others
5. Anti-Thyroid Drugs Market Regional And Country Analysis
5.1. Global Anti-Thyroid Drugs Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
5.2. Global Anti-Thyroid Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

6. Asia-Pacific Anti-Thyroid Drugs Market
6.1. Asia-Pacific Anti-Thyroid Drugs Market Overview
6.2. Asia-Pacific Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
6.3. Asia-Pacific Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

7. China Anti-Thyroid Drugs Market
7.1. China Anti-Thyroid Drugs Market Overview
7.2. China Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion
7.3. China Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion

8. India Anti-Thyroid Drugs Market
8.1. India Anti-Thyroid Drugs Market Overview
8.2. India Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
8.3. India Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

9. Japan Anti-Thyroid Drugs Market
9.1. Japan Anti-Thyroid Drugs Market Overview
9.2. Japan Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
9.3. Japan Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

10. Australia Anti-Thyroid Drugs Market
10.1. Australia Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
10.2. Australia Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

11. Indonesia Anti-Thyroid Drugs Market
11.1. Indonesia Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
11.2. Indonesia Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

12. South Korea Anti-Thyroid Drugs Market
12.1. South Korea Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
12.2. South Korea Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

13. Western Europe Anti-Thyroid Drugs Market
13.1. Western Europe Anti-Thyroid Drugs Market Overview
13.2. Western Europe Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
13.3. Western Europe Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

14. UK Anti-Thyroid Drugs Market
14.1. UK Anti-Thyroid Drugs Market Overview
14.2. UK Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
14.3. UK Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

15. Germany Anti-Thyroid Drugs Market
15.1. Germany Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
15.2. Germany Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

16. France Anti-Thyroid Drugs Market
16.4. France Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
16.5. France Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

17. Eastern Europe Anti-Thyroid Drugs Market
17.1. Eastern Europe Anti-Thyroid Drugs Market Overview
17.2. Eastern Europe Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
17.3. Eastern Europe Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

18. Russia Anti-Thyroid Drugs Market
18.1. Russia Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
18.2. Russia Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

19. North America Anti-Thyroid Drugs Market
19.1. North America Anti-Thyroid Drugs Market Overview
19.2. North America Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
19.3. North America Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

20. USA Anti-Thyroid Drugs Market
20.1. USA Anti-Thyroid Drugs Market Overview
20.2. USA Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
20.3. USA Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

21. South America Anti-Thyroid Drugs Market
21.1. South America Anti-Thyroid Drugs Market Overview
21.2. South America Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
21.3. South America Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

22. Brazil Anti-Thyroid Drugs Market
22.1. Brazil Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
22.2. Brazil Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

23. Middle East Anti-Thyroid Drugs Market
23.1. Middle East Anti-Thyroid Drugs Market Overview
23.2. Middle East Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
23.3. Middle East Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

24. Africa Anti-Thyroid Drugs Market
24.1. Africa Anti-Thyroid Drugs Market Overview
24.2. Africa Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
24.3. Africa Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

25. Anti-Thyroid Drugs Market Competitive Landscape And Company Profiles
25.1. Anti-Thyroid Drugs Market Competitive Landscape
25.2. Anti-Thyroid Drugs Market Company Profiles
25.2.1. Mylan N.V.
25.2.1.1. Overview
25.2.1.2. Products and Services
25.2.1.3. Strategy
25.2.1.4. Financial Performance
25.2.2. Abbott Laboratories
25.2.2.1. Overview
25.2.2.2. Products and Services
25.2.2.3. Strategy
25.2.2.4. Financial Performance
25.2.3. GlaxoSmithKline plc
25.2.3.1. Overview
25.2.3.2. Products and Services
25.2.3.3. Strategy
25.2.3.4. Financial Performance
25.2.4. Merck & Co.
25.2.4.1. Overview
25.2.4.2. Products and Services
25.2.4.3. Strategy
25.2.4.4. Financial Performance
25.2.5. AbbVie, Inc
25.2.5.1. Overview
25.2.5.2. Products and Services
25.2.5.3. Strategy
25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Anti-Thyroid Drugs Market

27. Anti-Thyroid Drugs Market Trends And Strategies

28. Product Pipeline Analysis

29. Anti-Thyroid Drugs Market Future Outlook and Potential Analysis

30. Appendix
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • AbbVie Inc
  • Allergan
  • Amgen Inc
  • GlaxoSmithKline plc
  • Lannett Company Inc.
  • MORE
The anti-thyroid drugs market consists of sales of anti-thyroid drugs and related services which are used for the treatment of hyperthyroidism. Hyperthyroidism is caused by over production of thyroid hormones in children, adults and pregnant women. Anti-thyroid class of drugs are also called thionamides which block the formation of thyroid hormone from over active thyroid gland.

The global anti-thyroid drugs market was valued at about $2.46 billion in 2018 and is expected to grow to $2.79 billion at a CAGR of 3.2% through 2022.

The anti-thyroid drugs market has been geographically segmented into North America, Western Europe, APAC, Eastern Europe, South America and Middle East & Africa. The North American market is the largest market for Anti-Thyroid Drugs and is expected to continue to be the largest market during the forecast period.

Graves’ disease is one of the direct causes of hyperthyroidism and the incidence of Graves’ disease increasing. In 2018, nearly 384,500 people were suffering from Graves’ disease in the seven major market across the globe and the USA accounted for the highest reported cases with a prevalence of 1.2%. Owing to the rising number of Grave’s disease, people suffering from hyperthyroidism is also increasing. This results in the overall growth in the demand for anti-thyroid drugs thereby driving the market.

The anti-thyroid drugs market is being restrained by the side effects of medication used to treat hyperthyroidism condition. There are many side effects associated with the medication used to treat hyperthyroidism. For instance, according to a study it was found that two most commonly used anti-thyroid medications propylthiouracil (PTU) and methimazole (MMI) causes hepatotoxicity and death in children and major abnormalities in the fetus.

Associations for thyroid care are launching initiatives to spread more awareness about thyroid disorders, update on the recent treatment methods and other summaries regarding various research on thyroid disorders. In the USA, nearly 60% of population suffering from hyperthyroidism are unaware and remain undiagnosed. To curb these issues, associations including American Thyroid Association (ATA) are making an impact by educating people about thyroid disorders. Similarly, the Thyroid foundation of Canada has also initiated awareness to awaken public interest and awareness about thyroid diseases including hyperthyroidism. Other associations that are launching initiatives and awareness programs include American Academy of Otolaryngology, British Thyroid Foundation among others.

Major players in the market are Mylan N.V., Abbott Laboratories, GlaxoSmithKline plc, Merck & Co. and AbbVie, Inc.
Note: Product cover images may vary from those shown
5 of 5
  • Mylan N.V.
  • Abbott Laboratories
  • GlaxoSmithKline plc
  • Merck & Co.
  • AbbVie Inc
  • Pfizer Inc.
  • Allergan
  • plc.
  • RLC LABS
  • Amgen Inc
  • Lannett Company Inc.
Note: Product cover images may vary from those shown
6 of 5

Loading
LOADING...

Adroll
adroll